Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Cipla

    Tag: cipla

    You Searched For "Cipla"
    Cipla, B J Wadia Hospital enter partnership to set up paediatric palliative care unit

    Cipla, B J Wadia Hospital enter partnership to set up paediatric palliative care unit

    Medical Dialogues Bureau7 Sept 2019 9:40 AM IST
    Cipla Foundation strongly believes that palliative care focuses on providing relief from symptoms and stress of illness at any point, yet most...
    DOP junks Cipla plea to refix MRP of Tafmune–EM

    DOP junks Cipla plea to refix MRP of Tafmune–EM

    Farhat Nasim2 Sept 2019 4:34 PM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...
    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    Farhat Nasim31 Aug 2019 2:35 PM IST
    New Delhi: A lobby of 8.5 lakh chemists across the country is planning to boycott the products manufactured by Cipla if the company enters the e...
    NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details

    NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details

    Farhat Nasim16 Aug 2019 4:01 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Farhat Nasim30 July 2019 2:08 PM IST
    New Delhi: The patent protection of blockbuster anti-diabetic drug Vildagliptin manufactured by the Swiss drugmaker, Novartis, will soon expire on...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details

    NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details

    Farhat Nasim27 Jun 2019 4:07 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

    Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

    Meghna A Singhania23 Jun 2019 4:57 PM IST
    New Delhi: Allowing the review petition of Zydus Healthcare Limited regarding price fixation of Tiotropium Inhalation (MDI) 9 mcg/dose, the Department...
    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Farhat Nasim16 Jun 2019 11:44 AM IST
    New Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority...
    CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details

    CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details

    Farhat Nasim6 Jun 2019 12:11 PM IST
    New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has recently released an updated list of WHO GMP...
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Farhat Nasim4 Jun 2019 5:44 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Cipla plans to file over dozen new drug applications for FY20

    Cipla plans to file over dozen new drug applications for FY20

    Garima27 May 2019 9:30 AM IST
    In another key market of South Africa, during the current fiscal year, Cipla is looking to strengthen its OTC (over-the-counter) business.New Delhi:...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok